EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use
EudraLex Volume 4, Chapter 1, revision 3 provides guidance for interpreting the GMP principles and guidelines for medicinal products laid down in Directive 2003/94/EC for human use and Directive 91/412/EEC for veterinary use. The legal basis for publishing the detailed guidelines is Article 47 of Directive 2001/83/EC and Article 51 of Directive 2001/82/EC; the revision aligns the chapter with ICH Q10 terminology, and the deadline for coming into operation is 31 January 2013.
The chapter sets out the principle that the holder of a Manufacturing Authorisation must manufacture medicinal products so they are fit for intended use, comply with the Marketing Authorisation or Clinical Trial Authorisation, and do not place patients at risk. It describes the Pharmaceutical Quality System, including Quality Management, senior management responsibility, management review, GMP requirements for medicinal products, and Quality Control.
31 January 2013.
It is revision 3.
To align with the concepts and terminology described in the ICH Q10 tripartite guideline on Pharmaceutical Quality System.